STAT+: FDA cites Dr. Reddy’s for quality control problems at a biologics plant
STAT
NOVEMBER 16, 2023
Reddy’s Laboratories, one of the world’s largest generic drugmakers, was cited by the U.S. Food and Drug Administration for a host of manufacturing violations at one of its plants in India, the latest instance in which the company was tagged by the regulator for quality-control problems.
Let's personalize your content